-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Voyager Therapeutics (VYGR)
-
-
-
-
-
-
-
Voyager Therapeutics chief medical officer to resign Feb. 20
-
-
-
-
-
-
-
Voyager Therapeutics (VYGR) Misses Q2 EPS by 4c
-
-
-
-
-
-
-
Voyager Therapeutics (VYGR) PT Lowered to $12 at Canaccord Genuity
-
-
-
-
-
-
-
Citi Starts Voyager Therapeutics (VYGR) at Buy
-
-
-
-
-
-
-
Voyager Therapeutics (VYGR) Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
-
-
-
456,136 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

